Indrayani Biotech is not a single operating company but a listed aggregator that buys controlling stakes in small, profitable Indian businesses, keeps their founders at the wheel, and wraps them in shared capital and central services to help them grow faster than they could alone. It was born from a 2020 court-approved merger that folded a power-electronics firm and an industrial caterer into a biotech shell that had barely begun trading, and it has since repeated that formula across dairy, pharma, boilers, agriculture and healthcare. The recurring approach is “inclusive growth” - acquire a brown-field MSME, leave the entrepreneur in charge, and plug it into the group’s finance, legal and procurement backbone.
Business segments
Five engines at different stages - a contract-catering cash cow, two consumer platforms at national scale, and a green-energy bet under construction - each built with the cash flows of the one before.
1. Food and hospitality: the group’s daily-bread business
A-Diet runs industrial canteens and facility-management contracts where clients stick around for more than six years on average, giving the group a steady, recurring base.
- Feeds institutions at scale - it supplies full-range contract catering to colleges, hospitals, corporate offices and factories across 12 states and 20 cities, with two central kitchens that can together turn out 50,000 meals a day plus several onsite kitchens.
- The kitchen is also a landlord - beyond food, it provides housekeeping, security, staff transport, manpower supply and building-management services, all added because existing industrial customers asked for them.
- Farm-to-fork, inside the group - its vegetables and groceries are grown by sister subsidiary HSL Agri Solutions using the group’s own bio-fertilisers, so A-Diet gets organic produce at bulk cost while the farm gets a guaranteed buyer.
- Retail brand on the side - it also operates the ‘Nalla Sappadu’ food-court chain in malls and IT parks, and has stretched into cloud kitchens, meal boxes and packed-food services.
2. Dairy: a protein factory that went from acquisition to IPO
Dindigul Farm Product takes 50,000 litres of milk a day straight from farmers, turns it into casein and whey protein for export, and was listed on the BSE SME platform within two years of being bought.
- Milk-to-protein, not milk-to-bottle - it makes milk-protein ingredients to European and American standards under the ‘EnNutrica’ brand, selling in bulk to customers in India and abroad, which earns foreign exchange.
- Farmers paid digitally, within days - roughly 50,000 litres of daily milk comes directly from farmers, with the balance from bulk suppliers; payments are made straight to their accounts soon after procurement.
- Clean power keeps costs down - a significant slice of its energy comes through alternate clean-energy power-purchase agreements at its subsidiary Dindigul Farm Product.
- The aggregation playbook in one deal - IBL’s material subsidiary converted to a public limited entity and went public on the SME exchange in June 2024, completing the full acquire-grow-list cycle.
3. Healthcare: a hospital-to-pharmacy chain stitched together by acquisition
IBL Healthcare runs eye and dental clinics, but its real weight comes from four bolt-on acquisitions that gave it a pharma factory, a South Indian distribution network, a syringe plant, and a chain of pharmacy stores.
- Owns a three-decade-old pharma plant - through step-down subsidiary Kniss Laboratories, it makes tablets, capsules, dry powders and liquid orals for both allopathy and ayurveda, with per-shift capacity of 20 lakh tablets and 8 lakh capsules, and exports to Eastern Europe, the Middle East and South-East Asia.
- Reaches 20,000 clinics - step-down Healthway India supplies medicines and equipment to over 400 distributors across South India, touching 20,000 clinics, nursing homes, corporate hospitals and pharmacies.
- Makes South India’s largest syringe output - associate Peekay Mediequip runs a 92,000 sq-ft sterile facility that can produce 1.7 million syringes a day, making it the fourth-largest syringe maker in India and the first to produce 3ml syringes in the country.
- Pharmacy retail with old-world goodwill - step-down Vaasan Medical Center operates the ‘Vasan Medical Hall’ chain in Trichy and nearby districts, with over 40 outlets at its peak and decades of local recognition.
- Cuts what does not fit - it exited a home-healthcare venture within a year because the model did not mesh with its clinic-and-product focus, showing a willingness to prune.
4. Engineering: two niche factories, one defence-and-railway customer list
Helios makes power electronics for submarines and satellite-launch consoles; Matrix makes industrial boilers for railways and process plants - both sell to customers who demand long certification cycles and then stay loyal.
- Power backup for mission-critical kit - Helios designs and builds industrial UPS systems, battery chargers, inverters and special-purpose machines, and has indigenised a 2x25 KW power supply for a defence submarine and the Pyro control console for ISRO’s satellite-launch facilities.
- Exports to nine countries - its installations run in Spain, Italy, South Africa, Sudan, UAE, Cambodia, Thailand, Nepal and Sri Lanka, and it has maintained two-decade distribution partnerships with Gammatronic of Israel and Gewiss of Italy.
- Boilers with a multi-fuel patent - Matrix Boilers holds a patent for energy-efficient hybrid boilers that can burn multiple fuels, and has manufactured more than 400 boilers globally, with a licence to build units up to 25 tonnes per hour.
- Empanelled with Southern Railway - it supplies boilers, boiler shells and containers for transporting diesel, petrol and crude oil to the railway, a customer that reorders on specification rather than price alone.
5. Agriculture and biotech: the circular supply chain
HSL Agri farms 100 acres with the group’s own bio-fertilisers, feeds the A-Diet kitchens, and is now adding a processing plant that buys from 30,000 farmers through 200 farmer-producer organisations.
- Organic farm, captive customer - HSL Agri grows organic vegetables, fruits and traditional paddy varieties on owned and leased land, using bio-fertilisers and bio-pest-controllers from the group’s Biotech division; all the produce is utilized by the A-Diet unit for supply of food to industries and other establishments, while the unit also trades surplus stock to other businesses in and around Chennai.
- The biotech shelf - the Biotech division sells a range of microbial products - Trichoderma, Beauveria, Potash Mobiliser, vermicompost and more - plus aquaculture feed supplements, and offers turnkey farm-advisory services from soil testing to nursery kits.
- Processing plant bought for a song - in May 2024, HSL Agri agreed to acquire Dilasa Agro Processors, which makes daal, tomato puree, mango pulp, bakery products and cattle feed under brands like Baliraja and Mr. Tom, sourcing raw material from roughly 200 FPOs that represent about 30,000 farmers.
- The loop closes - the Biotech division supplies the farm, the farm supplies the kitchen, and the kitchen’s organic waste can return as compost, making the whole chain a closed loop within the group.
Group structure and partners
Indrayani Biotech is a holding company with six direct subsidiaries and a multi-layered healthcare sub-group, all stitched together by a central shared-services engine.
- The listed parent holds direct stakes in six operating subsidiaries - Dindigul Farm Product (dairy, 31.34%), HSL Agri Solutions (agriculture, 90%), HSLPrime Properties (infrastructure, 76%), IBL Healthcare (healthcare, 100%), IBL Investments (finance, 99.94%) and Matrix Boilers (engineering, 51%) - plus three direct operating divisions: A-Diet, Helios and Biotech.
- IBL Healthcare is itself a sub-holding company with five step-down entities spanning pharma manufacturing (Kniss Laboratories, 53.125%), pharma distribution (Healthway India, 51%), pharmacy retail (Vaasan Medical Center, 100%), medical equipment (Peekay Mediequip, 36.92% with a path to control) and hospital operations (IBL Laksha Hospitals LLP, IBL Tiruvannamalai LLP).
- The group runs a shared-services backbone - finance, legal, IT, strategy, procurement and HR are centralised to squeeze out efficiencies across the diverse businesses.
- An in-house finance arm, IBL Investments Trust, created by IBL Investments Limited, has secured SEBI registration for a Category II Alternative Investment Fund, giving the group a structured vehicle to channel capital into future deals.
- Helios Solutions carries two-decade-old partnerships with Gammatronic (Israel) and Gewiss (Italy) for distributing and servicing their power-electronics products in India.